Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...

The semiconductor manufacturing equipment specialist reported record revenues in its fiscal 2024 fourth quarter.

Digi International (DGII) delivered earnings and revenue surprises of 4% and 0.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Coca-Cola (KO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Tower Semiconductor Ltd (NASDAQ: TSEM) reported a fiscal third-quarter 2024 revenue growth of 3.4% year-on-year to $370.51 ...

U.S. stock markets closed mixed on Wednesday as post-election rally shows signs of uncertainty. A key inflation data of October was in line with expectations. Third-quarter earnings results remained ...

The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at $1.73 per share, indicating 380.6% ...

Lyell Immunopharma (LYEL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

EVgo Inc (NASDAQ:EVGO) shares are trading higher after the company reported third-quarter sales growth of 92% year-on-year to ...

Tencent Music Entertainment Group's Q3 revenue grew 6.8% to $1.00 billion but missed analyst estimates. Online music revenue ...

Evercore ISI analysts on Thursday issued a negative tactical trading call on shares of Target Corporation (NYSE: TGT) and BJ's Wholesale Club Holdings (NYSE: BJ).